B-Vitamins, methylenetetrahydrofolate reductase (MTHFR) and hypertension

International Journal for Vitamin and Nutrition Research

Volumn 81, Issue 4, 2011, Pages 240-244

  Ward, Mary ^a   Wilson, Carol P ^a   Strain, J J ^a   Horigan, Geraldine ^a   Scott, John M ^b   McNulty, Helene ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

B vitamins; Hypertension; MTHFR; Riboflavin

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); COBALAMIN; FLAVINE ADENINE NUCLEOTIDE; FOLIC ACID; HOMOCYSTEINE; METHIONINE; METHYLENETETRAHYDROFOLIC ACID; PYRIDOXINE; RIBOFLAVIN; VITAMIN B GROUP; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); VITAMIN B COMPLEX;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DNA POLYMORPHISM; DRUG MEGADOSE; GENE FREQUENCY; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERTENSION; LOW DRUG DOSE; STROKE; GENETICS; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; RIBOFLAVIN; VITAMIN B COMPLEX;

EID: 84857966004     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831/a000069     Document Type: Article

References (24)

1. Lawes, C.M., Vander, H., S. and Rodgers, A. (2008) International Society of Hypertension. Global burden of blood-pressure-related disease. Lancet 371, 1513-8.
2. Chobanian, A.V., Bakris, G.L., Black, H.R. et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289(19), 2560-2572.
3. Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-13.
4. Gaziano, T.A., Bitton, A., Anand, S. and Weinstein, M.C. (2009) International Society of Hypertension. The global cost of nonoptimal blood pressure. J. Hypertens. 27, 1472-7.
5. Levy, D., DeStefano, A., Larson, L.M.G. et al. (2000) Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 36, 477-483.
6. Wang, X., Qin, X., Demirtas, H. et al. (2007) Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369, 1876-1882.
7. Wilcken, B., Bamforth, F., Li, Z., Zhu, H., Ritvanen, A., Renlund, M., Stoll, C ., Alembik, Y ., Dott, B., Czeizel, A.E., Gelman-Kohan, Z., Scarano, G., Bianca, S., Ettore, G., Tenconi, R., Bellato, S., Scala, I., Mutchinick, O.M., López, M.A., de Walle, H., Hofstra, R., Joutchenko, L., Kavteladze, L., Bermejo, E., Martínez-Frías, M.L., Gallagher, M., Erickson, J.D., Vollset, S.E., Mastroiacovo, P., Andria, G. and Botto, L.D. (2003) Geographical and ethnic variation of the 677C > T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J. Med. Genet. 40,619-25.
8. Yamada, K., Chen, Z., Rozen, R. and Matthews, R.G. (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc. Natl. Acad. Sci. U.S.A. 98, 14853-14858.
9. McNulty, H., Dowey, Le R.C., Strain, J.J, Dunne, A., Ward, M., Molloy, A.M., McAnena, L.B., Hughes, J.P., Hannon-Fletcher, M. and Scott, J.M. (2006) Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation 113, 74-80.
10. Wald, D.S., Law, M. and Morris, J.K. (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202-1208.
11. Klerk, M., Verhoef, P., Clarke, R., Blom, H.J., Kok, F.J. and Schouten, E.G. (2002) MTHFR Studies Collaboration Group. MTHFR C677T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288, 2023-2031.
12. Lewis, S.J., Ebrahim, S. and Davey-Smith, G. (2002) Meta-analysis of the MTHFR 677C → T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventative potential of folate. BMJ 331,1053-1059.
13. Nishio, H., Lee, M.J., Fujii, M. et al. (1996) A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population. Jpn. J. Hum. Genet. 41, 247-251.
14. Inamoto, N., Katsuya, T., Kokubo, Y. et al. (2003) Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke 34, 1628-1633.
15. Kosmas, I.P., Tatsioni, A., and Ioannidis, J.P. (2004) Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J. Hypertens. 22, 1655-1662.
16. Qian, X., Lu, Z., Tan, M., Liu, H. and Lu, D. (2007) A meta-analysis of the association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur. J. Hum. Genet. 15, 1239-1245.
17. Niu, W.Q., You, Y.G. and Qi, Y. (2011) Strong association of methylenetetrahydrofolate reductase gene C677T polymorphism with hypertension and hypertension-in-pregnancy in Chinese: a meta-analysis. J. Hum.Hypertens.
18. van Dijk, R.A., Rauwerda, J.A., Steyn, M., et al. (2001) Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebocontrolled trial. Arterioscler. Thromb. Vasc. Biol. 21, 2072-2079.
19. Mangoni, A.A., Sherwood, R.A., Swift, C.G. et al. (2002) Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J. Intern. Med. 252, 497-503.
20. Toole, J.F., Malinow, M.R., Chambless, L.E. et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291, 565-575.
21. McMahon, J.A., Skeaff, C.M., Williams, S.M. et al. (2007) Lowering homocysteine with B vitamins has no effect on blood pressure in older adults. J. Nutr. 137, 1183-1187.
22. Horigan, G., McNulty, H., Ward, M., Strain, J., Purvis, J. and Scott, J.M. (2010) Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C -> T polymorphism in MTHFR. J. Hypertens. 28, 478-86.
23. Wilson, C.P., Ward, M., McNulty, H., Horigan, G., Strain, J.J., Trouton, T., Purvis, J. and Scott, J.M. (2010) The MTHFR C677T polymorphism, blood pressure and riboflavin: a 4-year follow up study. Proceedings of the Nutrition Society 69 (OCE5), E373.
24. Antoniades, C., Shirodaria, C., Leeson, P., Baarholm, O.A., Van-Assche, T., Cunnington, C., Pillai, R., Ratnatunga, C., Tousoulis, D., Stefanadis, C., Refsum, H. and Channon, K.M. (2009) MTHFR 677 C > T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 119, 2507-15.